ARTICLE
22 February 2018

Navigating An FTC Drug Pricing Investigation

HP
Haug Partners

Contributor

Haug Partners is a full-service law firm that provides integrated multidisciplinary legal services for technology companies. Through relationships with firms in Germany, China, Japan, and other key international markets, Haug Partners has the resources, technical expertise, legal acumen, and business judgment to consistently deliver optimal outcomes for clients.
Antitrust Associate Amanda Hamilton published an article in FDLI's Update Magazine for the January-February 2018 Issue entitled "Navigating an FTC Drug Pricing Investigation
United States Food, Drugs, Healthcare, Life Sciences

Antitrust Associate Amanda Hamilton published an article in FDLI's Update Magazine for the January-February 2018 Issue entitled "Navigating an FTC Drug Pricing Investigation." The article provides insights into how the FTC handles drug pricing investigations, which can be a confusing process if you are unfamiliar with the FTC's policies and practices.

We may be hearing more about FTC drug pricing investigations in the future. During the confirmation hearing before the Senate, Nominee for FTC Chairman, Joe Simons, said he would create a taskforce at the FTC to monitor drug pricing which may lead to additional drug pricing investigations. Haug Partners lawyers are available to assist in addressing any questions you have regarding an FTC drug pricing investigation. Please contact any member of the firm's Antitrust practice group.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More